{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:05:17Z","timestamp":1773900317662,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04541-x","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:19:39Z","timestamp":1738999179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of parathyroidectomy on inflammatory and cardiovascular risk parameters in primary hyperparathyroidism: a retrospective analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Nese","family":"Bulbul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suat","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fettah","family":"Acibucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"issue":"3","key":"4541_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4183\/aeb.2021.323","volume":"17","author":"H Anderson","year":"2021","unstructured":"Anderson H, Lim KH, Simpson D, Gull S, Oprean R, Lee F, Kakos C, Cvasciuc IT. Correlation between biochemical features and outcomes of preoperative imaging (SPECT-CT and Ultrasound) in primary hyperparathyroidism. Acta Endocrinol (Buchar). 2021;17(3):323\u201330. https:\/\/doi.org\/10.4183\/aeb.2021.323","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"2","key":"4541_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1245\/s10434-018-6998-0","volume":"26","author":"S Sho","year":"2019","unstructured":"Sho S, Kuo EJ, Chen AC, Li N, Yeh MW, Livhits MJ. Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism. Ann Surg Oncol. 2019;26(2):539\u201346. https:\/\/doi.org\/10.1245\/s10434-018-6998-0","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4541_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, Haigh PI, Adams AL. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122\u20139. https:\/\/doi.org\/10.1210\/jc.2012-4022","journal-title":"J Clin Endocrinol Metab"},{"key":"4541_CR4","doi-asserted-by":"publisher","unstructured":"Richert L, Trombetti A, Herrmann FR, Triponez F, Meier C, Robert JH, Rizzoli R. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly 139 2009;(27\u201328):400\u2013404. https:\/\/doi.org\/10.4414\/smw.2009.12635","DOI":"10.4414\/smw.2009.12635"},{"key":"4541_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","volume":"73","author":"ML Griebeler","year":"2015","unstructured":"Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965\u20132010). Bone. 2015;73:1\u20137. https:\/\/doi.org\/10.1016\/j.bone.2014.12.003","journal-title":"Bone"},{"issue":"1","key":"4541_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-1093-4","volume":"19","author":"S Beysel","year":"2019","unstructured":"Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M, Cakal E. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord. 2019;19(1):1\u20138. https:\/\/doi.org\/10.1186\/s12872-019-1093-4","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"4541_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/EJE-17-0485","volume":"177","author":"J Pepe","year":"2017","unstructured":"Pepe J, Cipriani C, Sonato C, Raimo O, Biamonte F, Minisola S. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017;177(6):297\u2013308. https:\/\/doi.org\/10.1530\/EJE-17-0485","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4541_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/cen.12952","volume":"84","author":"GB Cansu","year":"2016","unstructured":"Cansu GB, Yilmaz N, Ozdem S, Balci MK, Suleymanlar G, Arici C, Boz A, Sari R, Altunbas HA. Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. Clin Endocrinol (Oxf). 2016;84(1):39\u201347. https:\/\/doi.org\/10.1111\/cen.12952","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"4541_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4183\/aeb.2020.497","volume":"16","author":"A Chopra","year":"2020","unstructured":"Chopra A, Bansal R, Sharma N, Kulshreshtha B. Parathyroid adenoma within the Carotid Sheath. Acta Endocrinol (Buchar). 2020;16(4):497\u2013500. https:\/\/doi.org\/10.4183\/aeb.2020.497","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"4","key":"4541_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.5114\/aoms.2018.74758","volume":"15","author":"HB Lam","year":"2019","unstructured":"Lam HB, Yang PS, Chien MN, Lee JJ, Chao LF, Cheng SP. Association between neutrophil-to-lymphocyte ratio and parathyroid hormone in patients with primary hyperparathyroidism. Arch Med Sci. 2019;15(4):880\u20136. https:\/\/doi.org\/10.5114\/aoms.2018.74758","journal-title":"Arch Med Sci"},{"key":"4541_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jss.2017.12.016","volume":"224","author":"PS Yang","year":"2018","unstructured":"Yang PS, Liu CL, Liu TP, Chen HH, Wu CJ, Cheng SP. Parathyroidectomy decreases neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios. J Surg Res. 2018;224:169\u201375. https:\/\/doi.org\/10.1016\/j.jss.2017.12.016","journal-title":"J Surg Res"},{"issue":"4","key":"4541_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4149\/endo_2014_04_182","volume":"48","author":"H Yilmaz","year":"2014","unstructured":"Yilmaz H. Assessment of mean platelet volume (MPV) in primary hyperparathyroidism: effects of successful parathyroidectomy on MPV levels. Endocr Regul. 2014;48(4):182\u20138. https:\/\/doi.org\/10.4149\/endo_2014_04_182","journal-title":"Endocr Regul"},{"issue":"2","key":"4541_CR13","first-page":"94","volume":"33","author":"M K\u0131z\u0131lg\u00fcl","year":"2018","unstructured":"K\u0131z\u0131lg\u00fcl M, \u00c7al\u0131\u015fkan M, U\u00e7an B, Beysel S, Tak\u0131r M, Sencar E, Sak\u0131z D, \u00c7akal E, \u00d6zbek M. Monocyte to HDL Cholesterol Ratio and its association with cardio-metabolic risk factors in primary hyperparathyroidism. Medeniyet Med J. 2018;33(2):94\u20139.","journal-title":"Medeniyet Med J"},{"issue":"1","key":"4541_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-020-02519-7","volume":"72","author":"M Yavari","year":"2021","unstructured":"Yavari M, Feizi A, Haghighatdoost F, Ghaffari A, Rezvanian H. The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis. Endocrine. 2021;72(1):72\u201385. https:\/\/doi.org\/10.1007\/s12020-020-02519-7","journal-title":"Endocrine"},{"issue":"4","key":"4541_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bjoms.2019.03.007","volume":"57","author":"F Borumandi","year":"2019","unstructured":"Borumandi F, Daultrey H, Laji K, Bosman D, Ashford N, Alam P. Detectability and surgical outcomes in parathyroid surgery - a single-centre experience. Br J Oral Maxillofac Surg. 2019;57(4):330\u20135. https:\/\/doi.org\/10.1016\/j.bjoms.2019.03.007","journal-title":"Br J Oral Maxillofac Surg"},{"key":"4541_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/IJGM.S253246","volume":"13","author":"S Hassani","year":"2020","unstructured":"Hassani S, Afkhamizadeh M, Teimouri A, Najaf Najafi M, Vazifeh Mostaan L, Mohebbi M. Evaluation of serum level of FGF23 and 1,25(OH)2D3 in primary hyperparathyroidism patients before and after parathyroidectomy. Int J Gen Med. 2020;13:289\u201395. https:\/\/doi.org\/10.2147\/IJGM.S253246","journal-title":"Int J Gen Med"},{"key":"4541_CR17","doi-asserted-by":"publisher","unstructured":"Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M, Cakal E. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord. 2019;19(1). https:\/\/doi.org\/10.1186\/s12872-019-1093-4","DOI":"10.1186\/s12872-019-1093-4"},{"issue":"1","key":"4541_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/cen.12952","volume":"84","author":"GB Cansu","year":"2015","unstructured":"Cansu GB, Y\u0131lmaz N, \u00d6zdem S, Balc\u0131 MK, S\u00fcleymanlar G, Ar\u0131c\u0131 C, Boz A, Sar\u0131 R, Altunba\u015f HA. Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. Clin Endocrinol. 2015;84(1):39\u201347. https:\/\/doi.org\/10.1111\/cen.12952","journal-title":"Clin Endocrinol"},{"key":"4541_CR19","doi-asserted-by":"publisher","unstructured":"Hassani S, Afkhamizadeh M, Teimouri A, Najaf Najafi M, Vazifeh Mostaan L, Mohebbi M. \u2009<\u2009p\u2009>\u2009Evaluation of Serum Level of FGF23 and 1,25(OH)\u2009<\u2009sub\u2009>\u20092\u2009D\u2009<\u2009sub\u2009>\u20093<\/sub\u2009>\u2009 in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy <\/p>. International Journal of General Medicine 2020;13:289\u2013295. https:\/\/doi.org\/10.2147\/ijgm.S253246","DOI":"10.2147\/ijgm.S253246"},{"issue":"1","key":"4541_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-020-02519-7","volume":"72","author":"M Yavari","year":"2020","unstructured":"Yavari M, Feizi A, Haghighatdoost F, Ghaffari A, Rezvanian H. The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis. Endocrine 2020;72(1):72\u201385. https:\/\/doi.org\/10.1007\/s12020-020-02519-7","journal-title":"Endocrine"},{"key":"4541_CR21","doi-asserted-by":"publisher","unstructured":"Pandzic Jaksic V, Majic A, Rezic T, Andric J, Jaksic O, Zrilic A, Marusic S. Primary Hyperparathyroidism Detected by Parathyroid Incidentaloma: Clinical Features, Work-up and Management. Acta Endocrinol (Buchar) 2021;17(2):219\u2013225. https:\/\/doi.org\/10.4183\/aeb.2021.219","DOI":"10.4183\/aeb.2021.219"},{"key":"4541_CR22","doi-asserted-by":"publisher","unstructured":"Turan U, Kilavuz H, Irkorucu O. Clinical Features of Hypercalcemic Crisis in Primary Hyperparathyroidism.Acta Endocrinol (Buchar) 2021;17(4):493\u2013497. https:\/\/doi.org\/10.4183\/aeb.2021.493","DOI":"10.4183\/aeb.2021.493"},{"key":"4541_CR23","doi-asserted-by":"publisher","unstructured":"Deng Y, Wang J, Liu H, Liu J, Xu J. Primary hyperparathyroidism associated with non-Hodgkin lymphoma: a case report and literature review.Postgrad Med 2020;132(4):398\u2013401. https:\/\/doi.org\/10.1080\/00325481.2020.1728979","DOI":"10.1080\/00325481.2020.1728979"},{"key":"4541_CR24","doi-asserted-by":"publisher","unstructured":"Maruani G, Corniere N, Nicolet L, Baron S, Courbebaisse M, Renaud S, Houillier P. [Primary hyperparathyroidism].Rev Med Interne 2013;34(10):605\u2013613. https:\/\/doi.org\/10.1016\/j.revmed.2012.10.369","DOI":"10.1016\/j.revmed.2012.10.369"},{"key":"4541_CR25","doi-asserted-by":"publisher","unstructured":"Bollerslev J, Sjostedt E, Rejnmark L. Cardiovascular consequences of parathyroid disorders in adults.Ann Endocrinol (Paris) 2021;82(3):151\u2013157. https:\/\/doi.org\/10.1016\/j.ando.2020.02.003","DOI":"10.1016\/j.ando.2020.02.003"},{"key":"4541_CR26","doi-asserted-by":"publisher","unstructured":"Badimon L, Vilahur G, Rocca B, Patrono C. The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis.Cardiovasc Res 2021;117(9):2001\u20132015. https:\/\/doi.org\/10.1093\/cvr\/cvab003","DOI":"10.1093\/cvr\/cvab003"},{"key":"4541_CR27","doi-asserted-by":"publisher","unstructured":"Kurtul A, Ornek E. Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review.Angiology 2019;70(9):802\u2013818. https:\/\/doi.org\/10.1177\/0003319719845186","DOI":"10.1177\/0003319719845186"},{"key":"4541_CR28","doi-asserted-by":"publisher","unstructured":"Song L, Chen RZ, Zhao XX, Sheng ZX, Zhou P, Liu C, Li JN, Zhou JY, Wang Y, Zhao HJ, Yan HB. Mean Platelet Volume\/Platelet Count Ratio and Culprit Plaque Morphologies: An Optical Coherence Tomography Study in Patients with ST Segment Elevation Myocardial Infarction.J Cardiovasc Transl Res 2021;3(1):1\u201311. https:\/\/doi.org\/10.1007\/s12265-021-10113-z","DOI":"10.1007\/s12265-021-10113-z"},{"key":"4541_CR29","doi-asserted-by":"publisher","unstructured":"Song A, Zhao H, Yang Y, Liu S, Nie M, Wang O, Xing X. Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis.J Endocrinol Invest 2021;44(8):1667\u20131677. https:\/\/doi.org\/10.1007\/s40618-020-01473-5","DOI":"10.1007\/s40618-020-01473-5"},{"key":"4541_CR30","doi-asserted-by":"publisher","unstructured":"Kabadi UM. Low 25-Hydroxyvitamin D in Primary Hyperparathyroidism: Enhanced Conversion Into 1,25-Hydroxyvitamin D May Not Be True Deficiency.JBMR Plus 2020;4(11):1\u20134. https:\/\/doi.org\/10.1002\/jbm4.10415","DOI":"10.1002\/jbm4.10415"},{"key":"4541_CR31","doi-asserted-by":"publisher","unstructured":"Rao SD, Miragaya J, Parikh N, Honasoge M, Springer K, Van Harn M, Divine GW. Effect of vitamin D nutrition on disease indices in patients with primary hyperparathyroidism.J Steroid Biochem Mol Bio 2020;l201:1\u20136. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105695","DOI":"10.1016\/j.jsbmb.2020.105695"},{"key":"4541_CR32","doi-asserted-by":"publisher","unstructured":"Rojas AP, Fain K, Peiris AN. Resolution of hypercalcemia in primary hyperparathyroidism with vitamin D replacement.Proc (Bayl Univ Med Cent) 2020;33(1):40\u201341. https:\/\/doi.org\/10.1080\/08998280.2019.1680060","DOI":"10.1080\/08998280.2019.1680060"},{"key":"4541_CR33","doi-asserted-by":"crossref","unstructured":"Kir S, Polat C. Effects of preoperative calcium levels and parathyroidectomy on renal function in primary hyperparathyroidism: a retrospective study.Croat Med J 2020;61(1):33\u201339","DOI":"10.3325\/cmj.2020.61.33"},{"key":"4541_CR34","doi-asserted-by":"publisher","unstructured":"Hayiroglu MI, Cinar T, Cinier G, Pay L, Yumurtas AC, Tezen O, Eren S, Kolak Z, Cetin T, Cicek V, Tekkesin AI. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction.Pacing Clin Electrophysio. 2022;l45(2):188\u2013195. https:\/\/doi.org\/10.1111\/pace.14436","DOI":"10.1111\/pace.14436"},{"key":"4541_CR35","doi-asserted-by":"publisher","unstructured":"Tezen O, Hayiroglu MI, Pay L, Yumurtas AC, Keskin K, Cetin T, Dereli S, Kadigoglu H, Yucedag FF, Arter E, Dayi SU. The role of systemic immune-inflammatory index in predicting contrast-induced nephropathy in non-ST-segment elevation myocardial infarction cases.Biomark Med. 2024;18(21\u201322):937\u2013944. https:\/\/doi.org\/10.1080\/17520363.2024.2415284","DOI":"10.1080\/17520363.2024.2415284"},{"key":"4541_CR36","doi-asserted-by":"publisher","unstructured":"Saylik F, Cinar T, Selcuk M, Akbulut T, Hayiroglu MI, Tanboga IH. Evaluation of Naples Score for Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.Angiology. 2024;75(8):725\u2013733. https:\/\/doi.org\/10.1177\/00033197231170982","DOI":"10.1177\/00033197231170982"},{"key":"4541_CR37","doi-asserted-by":"publisher","unstructured":"Pay L, Cetin T, Keskin K, Dereli S, Tezen O, Yumurtas AC, Kolak Z, Eren S, Saylik F, Cinar T, Hayiroglu MI. Evaluation of Naples prognostic score to predict long-term mortality in patients with pulmonary embolism.Biomark Med. 2024;18(6):253\u2013263. https:\/\/doi.org\/10.2217\/bmm-2023-0741","DOI":"10.2217\/bmm-2023-0741"},{"key":"4541_CR38","doi-asserted-by":"publisher","unstructured":"Cinar T, Saylik F, Akbulut T, Korkmaz Y, Cicek V, Asal S, Erdem A, Selcuk M, Hayiroglu MI. Evaluation of Intermountain Risk Score for Short- and Long-Term Mortality in ST Elevation Myocardial Infarction Patients.Angiology. 2023;74(4):357\u2013364. https:\/\/doi.org\/10.1177\/00033197221105753","DOI":"10.1177\/00033197221105753"},{"key":"4541_CR39","doi-asserted-by":"publisher","unstructured":"Mert Ilker H, Faysal S, Ahmet Cagdas Y, Murat S, Tufan C, Prognostic value of Intermountain Risk Score for short- and long-term mortality in patients with cardiogenic shock.Coron Artery Dis. 2023;34(2):154\u2013159. https:\/\/doi.org\/10.1097\/MCA.0000000000001219","DOI":"10.1097\/MCA.0000000000001219"},{"key":"4541_CR40","doi-asserted-by":"publisher","unstructured":"Wang YS, Niu L, Shi WX, Li XY, Shen L. Naples prognostic score as a predictor of outcomes in lung cancer: a systematic review and meta-analysis.Eur Rev Med Pharmacol Sci. 2023;27(17):8144\u20138153. https:\/\/doi.org\/10.26355\/eurrev_202309_33574","DOI":"10.26355\/eurrev_202309_33574"},{"key":"4541_CR41","doi-asserted-by":"publisher","unstructured":"Balta S. Endothelial Dysfunction and Inflammatory Markers of Vascular Disease.Curr Vasc Pharmaco. 2021;l19(3):243\u2013249. https:\/\/doi.org\/10.2174\/1570161118666200421142542","DOI":"10.2174\/1570161118666200421142542"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04541-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04541-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04541-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:19:44Z","timestamp":1738999184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04541-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4541"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04541-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the decision of Health Sciences University Adana City Hospital Local Ethics Committee (2020\/10, 29\/01\/2020). The Declaration of Helsinki protocol was followed in the research protocol. All procedures involving human participants in this study were conducted in compliance with the ethical standards set by the institutional research committee and in alignment with the 1964 Helsinki Declaration and its subsequent amendments or similar ethical standards. Participants were recruited only after providing written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}